Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed™ 780G system¹, compared to insuli...

First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in...

Related Keywords

Ireland ,Dublin ,Kendra Cassillo ,Ohad Cohen ,Prnewswire Medtronic ,Ryan Weispfenning ,Exchange Commission ,Linkedin ,Drug Administration ,Complications Trial Research Group ,Medtronic ,Our Mission ,Lancet Diabetes ,Orange Improvements ,Those That Transitioned ,More Participants Achieved Glycemic Targets ,Diabetes Business ,Diabetes Treatment Satisfaction Questionnaire ,Diabetes Control ,Complications Trial Research ,New England Journal ,Advanced Hybrid Closed Loop ,Tech Ther ,Results From ,People With Type ,Diab Care ,